Halozyme Therapeutics Inc (HALO)

[rod5247]

What are their results in stage IV PDA? Apples and oranges.

Two independent researchers are running trials with PEG.

Recruiting Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Condition:
Pancreatic Cancer

Interventions:
Drug: PEGPH20; Drug: Cetuximab; Device: DW & DCE-MRI; Other: blood draws

Phase:


Sponsor/Collaborators:
Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Weizmann Institute of Science

Study Start:
September 2014

Primary Completion:
September 2016

First Received:
September 12, 2014

Last Updated:
February 9, 2016

Recruiting PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Condition:
Adenocarcinoma

Interventions:
Drug: PEGPH20; Drug: Gemcitabine; Drug: Nab-paclitaxel

Phase:
Phase 2

Sponsor/Collaborators:
Andrew Ko; University of California, San Francisco

Study Start:
July 2015

Primary Completion:
December 2019

First Received:
June 29, 2015

Last Updated:
December 29, 2015